Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$10.23 - $19.34 $6,199 - $11,720
606 Added 606.0%
706 $10,000
Q2 2022

Jul 19, 2022

BUY
$3.74 - $10.66 $374 - $1,066
100 New
100 $0
Q1 2022

Apr 29, 2022

SELL
$7.81 - $20.45 $1,952 - $5,112
-250 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$15.2 - $35.51 $760 - $1,775
50 Added 25.0%
250 $5,000
Q3 2021

Oct 29, 2021

SELL
$21.78 - $40.45 $2,591 - $4,813
-119 Reduced 37.3%
200 $7,000
Q1 2021

Apr 29, 2021

BUY
$41.61 - $54.3 $790 - $1,031
19 Added 6.33%
319 $15,000
Q2 2020

Jul 20, 2020

SELL
$8.9 - $21.84 $890 - $2,184
-100 Reduced 25.0%
300 $6,000
Q1 2020

Apr 14, 2020

SELL
$7.14 - $15.99 $714 - $1,599
-100 Reduced 20.0%
400 $4,000
Q4 2019

Jan 27, 2020

SELL
$5.1 - $11.2 $1,019 - $2,240
-200 Reduced 28.57%
500 $6,000
Q1 2019

Apr 11, 2019

BUY
$4.02 - $8.04 $401 - $803
100 Added 16.67%
700 $6,000
Q4 2018

Jan 17, 2019

BUY
$3.44 - $5.76 $1,032 - $1,728
300 Added 100.0%
600 $2,000
Q3 2018

Nov 02, 2018

BUY
$5.15 - $14.0 $1,030 - $2,800
200 Added 200.0%
300 $2,000
Q2 2018

Jul 27, 2018

BUY
$12.5 - $15.0 $1,250 - $1,500
100 New
100 $1,000
Q1 2018

Apr 30, 2018

SELL
$8.7 - $16.8 $1,739 - $3,360
-200 Closed
0 $0
Q3 2017

Oct 24, 2017

BUY
$10.0 - $12.7 $2,000 - $2,540
200
200 $2,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.